ArticleEuropean journal of medical research2026
Comparative performance of radiomics models based on 3D-FLAIR-CUBE and MPRAGE sequences gadolinium-induced labyrinth MRI protocols for predicting endolymphatic hydrops in Ménière's disease.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to develop and validate a radiomics-based machine learning model using 3D-FLAIR-CUBE and 3D MPRAGE gadolinium-induced labyrinth MRI protocols and accurately predict endolymphatic hydrops in unilateral Meniere's disease.
methodsThis retrospective study enrolled 175 patients with definite unilateral MD (2019-2023) who underwent three-dimensional cube liquid attenuation inversion recovery (3D-FLAIR-CUBE) and three-dimensional magnetization-prepared rapid gradient echo (3D-MPRAGE) MRI after intratympanic gadolinium injection. Radiomic features (n = 1666) from cochlear and vestibular regions were extracted using PyRadiomics, followed by feature selection the least absolute shrinkage and selection operator, (LASSO) regression and Pearson correlation. Three machine learning models logistic regression (LR), Naive Bayes (NB), and multilayer perceptron (MLP) were trained (80% data set) and tested (20%) to classify EH. Model performance was evaluated by AUC, accuracy, calibration curves and decision curve analysis (DCA).
resultsIn the modeling based on 3D-FLAIR-CUBE radiomic features, the machine learning models demonstrated strong capability in identifying the affected ear. The multilayer perceptron (MLP) model achieved an AUC of 0.914 in the training set and 0.815 in the test set. Analysis based on 3D-MPRAGE features yielded slightly lower yet still significant performance, with AUCs of 0.778 in the training set and 0.712 in the validation set. A combined model integrating features from both sequences showed AUCs of 0.913 and 0.814 for the training and test sets, respectively. However, DeLong's test indicated that the combined model did not provide a statistically significant improvement compared to the model using the CUBE sequence alone. Notably, the model based on 3D-FLAIR-CUBE outperformed that based on 3D-MPRAGE. Decision curve analysis further confirmed its favorable clinical net benefit. Importantly, feature selection revealed that vestibular features carried greater diagnostic weight than cochlear features in the final model, suggesting their higher relevance in identifying endolymphatic hydrops.
conclusionsThis study developed the first radiomics model based on gadolinium-induced labyrinth MRI using 3D-FLAIR-CUBE and 3D-MPRAGE sequences. The MLP model based on 3D-FLAIR-CUBE demonstrated the best diagnostic performance. Focusing on vestibular imaging features can improve the detection of endolymphatic hydrops. This tool may assist in guiding personalized treatment decisions, particularly for patients with refractory Ménière's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.